Other studies used sentinel lymph node analysis using one-step nucleic acid amplification (OSNA) has been proposed for intraoperative staging of breast cancer [18], [21], and in these studies cytokeratin 19 (CK19) was considered as the most appropriate marker due to its broad expression in breast carcinomas [18], [22]. The gene discussed is KRT19; the disease is breast carcinoma.